Hilton Capital Management, LLC
Source: SEC Form 13F · as of Mar 2026Hilton Capital Management, LLC holds 11 biotech & pharma companies tracked by BioSniper, totaling $69.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$69.1M
| Company | Shares | Value |
|---|---|---|
| AZNASTRAZENECA PLC | 73,991 | $14.6M |
| LLYELI LILLY & Co | 10,638 | $9.8M |
| DGXQuest Diagnostics Incorporated | 49,211 | $9.6M |
| JNJJOHNSON & JOHNSON | 33,017 | $8.1M |
| AMGNAMGEN INC | 18,120 | $6.4M |
| ABTABBOTT LABORATORIES | 51,773 | $5.3M |
| MRKMerck & Co., Inc. | 37,392 | $4.5M |
| WSTWest Pharmaceutical Services Inc. | 17,043 | $4.3M |
| TECHBIO-TECHNE Corp | 59,288 | $3.1M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 11,333 | $3.1M |
| CGTXCOGNITION THERAPEUTICS INC | 548,950 | $417K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.